Drug Approval | July 24, 2022
Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
This is the 142nd ANDA (including 8 tentative approvals received) out of Eugia Pharma Specialty Group (EPSG) facilities, manufacturing both oral and sterile specialty products.
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores
Glenmark is the first company in India to market the innovative FDC of Indacaterol
Based on a post hoc analysis, fewer required respiratory interventions
To address the preventive & primary healthcare delivery gaps in India
Subscribe To Our Newsletter & Stay Updated
